Profiles for generic drugs starting with 'i'
✉ Email this page to a colleague
US Patents and Regulatory Information for i
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Superpharm | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 070488-001 | Oct 10, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 8,709,475 | ⤷ Start Trial | ⤷ Start Trial | |||
| Hisun Pharm Hangzhou | IRBESARTAN | irbesartan | TABLET;ORAL | 206194-002 | Jun 14, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novartis | FABHALTA | iptacopan hydrochloride | CAPSULE;ORAL | 218276-001 | Dec 5, 2023 | RX | Yes | Yes | 11,723,901 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
